AI Assistant
Blog
Pricing
Log In
Sign Up
Tocilizumab as a potential therapeutic option for children with severe, refractory juvenile localized scleroderma
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
